Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. STATE OF INSULIN PUMP USE IN THE CAPITAL REGION OF DENMARK

    Research output: Contribution to journalConference abstract in journalResearch

  3. Cost of Treating Skin Problems in Patients with Diabetes who Use Insulin Pumps and/or Glucose Sensors

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Insulin pump settings during breastfeeding in women with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor Site

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A New Stochastic Approach for Modeling Glycemic Disturbances in Type 2 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Does Subclinical Hypothyroidism Add Any Symptoms? evidence from a Danish population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter]

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

BACKGROUND: Hypoglycemia is an increasingly important endpoint in clinical diabetes trials. The assessment of hypoglycemia should therefore be as complete as possible. Blinded continuous glucose monitoring (CGM) provides an improved opportunity to capture asymptomatic and nocturnal events. Here we report results from the HypoAna trial comparing all-analog-insulin therapy (aspart/detemir) with all-human-insulin therapy (neutral protamine Hagedorn/regular) on non-severe hypoglycemia (symptomatic and asymptomatic hypoglycemia) as assessed by blinded CGM and compared with data obtained by self-monitoring of blood glucose (SMBG) in patients with type 1 diabetes and recurrent severe hypoglycemia.

METHODS: Fifty-three patients completed a substudy of 4 × 3 days of blinded CGM. CGM traces were reviewed for hypoglycemic events lasting 15 min or longer.

RESULTS: At the threshold ≤3.9 mmol/L, the per-protocol analysis demonstrated a 40% rate reduction (95% confidence interval [CI] 20%-60%; P = 0.002) in nocturnal non-severe hypoglycemia during analog treatment, mainly due to a 40% rate reduction (95% CI 0%-70%; P = 0.03) of nocturnal asymptomatic hypoglycemia. Similar nonsignificant trends were seen at the glucose threshold ≤3.0 mmol/L. Overall CGM-detected that nocturnal asymptomatic hypoglycemia ≤3.9 mmol/L was ∼17 times more frequent than SMBG-detected episodes (52 vs. 3 events/patient-year). This translates into a time needed to treat one patient with insulin analogs to prevent one episode that is 34 times shorter using CGM data than SMBG data (1.4 vs. 47 weeks).

CONCLUSIONS: Capturing hypoglycemic events by the conventional method of SMBG in patients with impaired awareness reveals only a limited number of events. Blinded CGM can provide more complete data, particularly in terms of asymptomatic and nocturnal events.

Original languageEnglish
JournalDiabetes Technology and Therapeutics
Volume20
Issue number3
Pages (from-to)247-256.
ISSN1520-9156
DOIs
Publication statusPublished - 1 Mar 2018

    Research areas

  • Journal Article

ID: 53475115